• Citer

Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.

par Coates, Alan;Keshaviah, A;Thürlimann, Beat;Mouridsen, Henning;Mauriac, Louis;Forbes, John F;Paridaens, R. ;Castiglione-Gertsch, Monica;Gelber, Richard;Colleoni, Marco Angelo;Lang, Istvan;Del Mastro, Lucia;Smith, Ian;Chirgwin, Jacquie;Nogaret, Jean-Marie ;Pienkowski, Tadeusz;Wardley, Andrew;Jakobsen, Erik H.;Price, K;Goldhirsch, Aron
Référence Journal of clinical oncology, 25, 5, page (486-492)
Publication Publié, 2007-02

Article révisé par les pairs

• Détails
• Contenu

Titre:	Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Auteur:	Coates, Alan; Keshaviah, A; Thürlimann, Beat; Mouridsen, Henning; Mauriac, Louis; Forbes, John F; Paridaens, R.; Castiglione-Gertsch, Monica; Gelber, Richard; Colleoni, Marco Angelo; Lang, Istvan; Del Mastro, Lucia; Smith, Ian; Chirgwin, Jacquie; Nogaret, Jean-Marie; Pienkowski, Tadeusz; Wardley, Andrew; Jakobsen, Erik H.; Price, K; Goldhirsch, Aron
Informations sur la publication:	Journal of clinical oncology, 25, 5, page (486-492)
Statut de publication:	Publié, 2007-02
Sujet CREF:	Cancérologie
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Antineoplastic Agents, Hormonal -- adverse effects -- therapeutic use
	Aromatase Inhibitors -- adverse effects -- therapeutic use
	Breast Neoplasms -- chemistry -- drug therapy -- pathology
	Chemotherapy, Adjuvant
	Disease-Free Survival
	Double-Blind Method
	Estrogen Antagonists -- adverse effects -- therapeutic use
	Female
	Follow-Up Studies
	Humans
	Kaplan-Meier Estimate
	Middle Aged
	Neoplasms, Hormone-Dependent -- chemistry -- drug therapy -- pathology
	Nitriles -- adverse effects -- therapeutic use
	Postmenopause
	Proportional Hazards Models
	Receptors, Estrogen -- analysis
	Receptors, Progesterone -- analysis
	Tamoxifen -- adverse effects -- therapeutic use
	Time Factors
	Treatment Outcome
	Triazoles -- adverse effects -- therapeutic use
Note générale:	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, N.I.H., Extramural
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2006.08.8617
	info:pii/JCO.2006.08.8617
	info:pmid/17200148